Soni Manmeet Singh 4
4 · Summit Therapeutics Inc. · Filed May 1, 2025
Insider Transaction Report
Form 4
Soni Manmeet Singh
DirectorCOO and CFO
Transactions
- Award
Stock Option (right to buy)
2025-04-29+11,200,000→ 11,200,000 totalExercise: $1.68Exp: 2033-10-13→ Common Stock (11,200,000 underlying)
Footnotes (2)
- [F1]Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025.
- [F2]Not applicable.